Skip to main content
OpenTrials

Clinical trial condition

Cutaneous Squamous Cell Carcinoma

Explore clinical trials studying Cutaneous Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.

56 public trials 20 recruiting studies
Refine in advanced search Browse all conditions

Cutaneous Squamous Cell Carcinoma trial results

Not Yet Recruiting

A Study of IDP-001 in Advanced or Metastatic Solid Tumors

NCT07602842

Conditions
Advanced Solid Tumor, Anus Diseases, Anus Neoplasms, +33 more
Locations
  • START Los Angeles Los Angeles, California, United States
  • Hackensack Meridian - John Theurer Cancer Center Edison, New Jersey, United States
  • START New York Long Island Lake Success, New York, United States
  • START Dallas Forth Worth Fort Worth, Texas, United States
View Trial Details
Completed

Study of Favezelimab Coformulated With Pembrolizumab (MK-4280A) in Participants With Selected Solid Tumors (MK-4280A-010)

NCT06036836

Conditions
Cutaneous Squamous Cell Carcinoma, Endometrial Cancer, Endometrial Neoplasms, +13 more
Locations
  • Yale-New Haven Hospital-Yale Cancer Center ( Site 0643) New Haven, Connecticut, United States
  • Dana-Farber Cancer Institute ( Site 0642) Boston, Massachusetts, United States
  • Rutgers Cancer Institute of New Jersey ( Site 0635) New Brunswick, New Jersey, United States
  • Duke Cancer Institute ( Site 0641) Durham, North Carolina, United States
View all 44 locations
View Trial Details
Completed

Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma

NCT03082534

Conditions
Carcinoma, Carcinoma, Squamous Cell, Cutaneous Squamous Cell Carcinoma, +37 more
Locations
  • UCSD Moores Cancer Center La Jolla, California, United States
  • University of California Los Angeles Cancer Center Los Angeles, California, United States
  • University of Michigan Cancer Center Ann Arbor, Michigan, United States
  • Washington School of Medicine Cancer Center St Louis, Missouri, United States
View Trial Details
Completed

Intralesional Cemiplimab for Adult Patients With Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma

NCT03889912

Conditions
Basal Cell Carcinoma, Carcinoma, Carcinoma, Basal Cell, +5 more
Locations
  • Medical Dermatology Specialists Phoenix, Arizona, United States
  • TCR Medical Corporation San Diego, California, United States
  • Dermatology Associates of the Palm Beaches Delray Beach, Florida, United States
  • MetroDerm Atlanta, Georgia, United States
View all 18 locations
View Trial Details
Completed

Study of Cemiplimab in Patients With Type of Skin Cancer Stage II to IV Cutaneous Squamous Cell Carcinoma

NCT04154943

Conditions
Cutaneous Squamous Cell Carcinoma
Locations
  • Regeneron Study Site Palo Alto, California, United States
  • Regeneron Study Site Washington D.C., District of Columbia, United States
  • Regeneron Study Site Miami, Florida, United States
  • Regeneron Study Site Tampa, Florida, United States
View all 22 locations
View Trial Details
Completed

CemiplimAb Survivorship Epidemiology

NCT03836105

Conditions
Basal Cell Carcinoma, Carcinoma, Carcinoma, Basal Cell, +5 more
Locations
  • Oncology Specialties, PC - Clearview Cancer Institute Huntsville, Alabama, United States
  • Dignity Health St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • CARTI Cancer Center Little Rock, Arkansas, United States
  • University of California San Diego La Jolla, California, United States
View all 53 locations
View Trial Details

Related conditions